In this presentation from Lymphoma & Myeloma 2016, Dr. Neil E. Kay discusses optimal approaches for the management of chronic lymphocytic leukemia (CLL) patients with deletion 17p.
Click to Earn CME Credit: http://bit.ly/2lDPthL
© 2016 Imedex, LLC.